The odd hiring would really worry me. But it looks like wholesale reorganisation along the neurohormonal axis. It certainly doesn't look like cost cutting which is odd for a company supposedly under a financial cloud. New CEO's get to make wholesale changes in personnel, so it looks to me like the new CEO has been at least defacto employed. You wouldn't do all these changes to redo them in a month or saddle a new CEO with a team he did not want.
Looks very bright to me.
- Forums
- ASX - By Stock
- SHC
- More Changes at SSH
More Changes at SSH, page-9
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online